Connection

Dariusz Dudek to Aged

This is a "connection" page, showing publications Dariusz Dudek has written about Aged.
Connection Strength

0.436
  1. Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI. J Am Coll Cardiol. 2020 11 17; 76(20):2321-2330.
    View in: PubMed
    Score: 0.016
  2. Characteristics of patients presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA) in Poland: data from the ORPKI national registry. J Thromb Thrombolysis. 2019 Apr; 47(3):462-466.
    View in: PubMed
    Score: 0.015
  3. Impact of sex on the follow-up course and predictors of clinical outcomes in patients hospitalised due to myocardial infarction with non-obstructive coronary arteries: a single-centre experience. Kardiol Pol. 2019; 77(2):198-206.
    View in: PubMed
    Score: 0.014
  4. Clinical outcomes in nonagenarians undergoing a percutaneous coronary intervention: data from the ORPKI Polish National Registry 2014-2016. Coron Artery Dis. 2018 11; 29(7):573-578.
    View in: PubMed
    Score: 0.014
  5. Psoriasis is an independent predictor of increased risk of allergic reaction during percutaneous coronary interventions. Big data analysis from the Polish National PCI Registry (ORPKI). Cardiol J. 2020; 27(3):278-284.
    View in: PubMed
    Score: 0.014
  6. Impact of On-Site Surgical Backup on Periprocedural Outcomes of Primary Percutaneous Interventions in Patients Presenting With ST-Segment Elevation Myocardial Infarction (From the ORPKI Polish National Registry). Am J Cardiol. 2018 09 15; 122(6):929-935.
    View in: PubMed
    Score: 0.014
  7. Usefulness of Psoas Muscle Area and Volume and Frailty Scoring to Predict Outcomes After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2018 07 01; 122(1):135-140.
    View in: PubMed
    Score: 0.014
  8. Efficacy and Safety of the HeartMate Percutaneous Heart Pump During High-Risk Percutaneous Coronary Intervention (from the SHIELD I Trial). Am J Cardiol. 2018 06 15; 121(12):1524-1529.
    View in: PubMed
    Score: 0.014
  9. Impact of previous cardiac surgery with sternotomy on clinical outcomes and quality of life after transcatheter aortic valve implantation for severe aortic stenosis. Kardiol Pol. 2018; 76(5):838-844.
    View in: PubMed
    Score: 0.013
  10. Contemporary use of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry. J Thromb Thrombolysis. 2018 Jan; 45(1):151-157.
    View in: PubMed
    Score: 0.013
  11. Impact of Pre-procedural Cerebrovascular Events on Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis. Curr Pharm Des. 2018; 24(5):641-646.
    View in: PubMed
    Score: 0.013
  12. Impact of chronic obstructive pulmonary disease and frailty on long-term outcomes and quality of life after transcatheter aortic valve implantation. Aging Clin Exp Res. 2018 Sep; 30(9):1033-1040.
    View in: PubMed
    Score: 0.013
  13. An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents. Catheter Cardiovasc Interv. 2018 08 01; 92(2):302-309.
    View in: PubMed
    Score: 0.013
  14. Reduced periprocedural mortality and bleeding rates of radial approach in ST-segment elevation myocardial infarction. Propensity score analysis of data from the ORPKI Polish National Registry. EuroIntervention. 2017 Sep 20; 13(7):843-850.
    View in: PubMed
    Score: 0.013
  15. In-hospital and long-term outcomes of percutaneous balloon aortic valvuloplasty with concomitant percutaneous coronary intervention in patients with severe aortic stenosis. J Interv Cardiol. 2018 Feb; 31(1):60-67.
    View in: PubMed
    Score: 0.013
  16. Effect of diabetes mellitus on clinical outcomes and quality of life after transcatheter aortic valve implantation for severe aortic valve stenosis. Hellenic J Cardiol. 2018 Mar - Apr; 59(2):100-107.
    View in: PubMed
    Score: 0.013
  17. Incidence of Postoperative Delirium and Its Impact on Outcomes After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2017 Oct 01; 120(7):1187-1192.
    View in: PubMed
    Score: 0.013
  18. Prognostic value of tricuspid regurgitation velocity and probability of pulmonary hypertension in patients undergoing transcatheter aortic valve implantation. Int J Cardiovasc Imaging. 2017 Dec; 33(12):1931-1938.
    View in: PubMed
    Score: 0.013
  19. Sex-Related Differences in Outcomes After Percutaneous Balloon Aortic Valvuloplasty. J Invasive Cardiol. 2017 Jun; 29(6):188-194.
    View in: PubMed
    Score: 0.013
  20. Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive Treatment. Int J Mol Sci. 2017 Apr 29; 18(5).
    View in: PubMed
    Score: 0.013
  21. Transcatheter aortic valve implantation improves carotid and vertebral arterial blood flow in patients with severe aortic stenosis: practical role of orthostatic stress test. Clin Cardiol. 2017 Jul; 40(7):492-497.
    View in: PubMed
    Score: 0.013
  22. Association Between Blood Transfusions and 12-Month Mortality After Transcatheter Aortic Valve Implantation. Int Heart J. 2017 Feb 07; 58(1):50-55.
    View in: PubMed
    Score: 0.012
  23. Long-term effects of rotational atherectomy in patients with heavy calcified coronary artery lesions: a single-centre experience. Kardiol Pol. 2017; 75(6):564-572.
    View in: PubMed
    Score: 0.012
  24. Impact of post-dilatation on the reduction of paravalvular leak and mortality after transcatheter aortic valve implantation. Kardiol Pol. 2017; 75(8):742-748.
    View in: PubMed
    Score: 0.012
  25. Impact of frailty on mortality after transcatheter aortic valve implantation. Am Heart J. 2017 Mar; 185:52-58.
    View in: PubMed
    Score: 0.012
  26. Prognostic significance of new onset atrial fibrillation in acute coronary syndrome patients treated conservatively. Cardiol J. 2010; 17(1):57-64.
    View in: PubMed
    Score: 0.008
  27. Characteristics of patients from the Polish Registry of Acute Coronary Syndromes during the COVID-19 pandemic: the first report. Kardiol Pol. 2021 02 25; 79(2):192-195.
    View in: PubMed
    Score: 0.004
  28. Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions. Catheter Cardiovasc Interv. 2020 11; 96(6):E568-E575.
    View in: PubMed
    Score: 0.004
  29. Long-term clinical outcomes of direct absorb bioresorbable vascular scaffold implantation in acute coronary syndrome. Minerva Cardioangiol. 2019 Oct; 67(5):374-379.
    View in: PubMed
    Score: 0.004
  30. Presence and characteristics of coronary artery fistulas among patients undergoing coronary angiography. Kardiol Pol. 2019 Nov 22; 77(11):1034-1039.
    View in: PubMed
    Score: 0.004
  31. Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial. Cardiovasc Revasc Med. 2019 Jul; 20(7):577-582.
    View in: PubMed
    Score: 0.004
  32. Impact of Coronary Artery Disease and Diabetes Mellitus on the Long-Term Follow-Up in Patients after Retrograde Recanalization of the Femoropopliteal Arterial Region. J Diabetes Res. 2019; 2019:6036359.
    View in: PubMed
    Score: 0.004
  33. The obesity paradox in patients undergoing transcatheter aortic valve implantation: is there any effect of body mass index on survival? Kardiol Pol. 2019; 77(2):190-197.
    View in: PubMed
    Score: 0.004
  34. Prevalence and clinical presentation of myocardial bridge on the basis of the National Polish Percutaneous Interventions Registry and the Classification of Rare Cardiovascular Diseases. Kardiol Pol. 2018 Dec 20; 77(4):465-470.
    View in: PubMed
    Score: 0.004
  35. Chronic obstructive pulmonary disease and periprocedural complications in patients undergoing percutaneous coronary interventions. PLoS One. 2018; 13(10):e0204257.
    View in: PubMed
    Score: 0.004
  36. A novel approach to quantification of aortic valve calcifications in patients undergoing transcatheter aortic valve implantation. Minerva Cardioangiol. 2019 Feb; 67(1):3-10.
    View in: PubMed
    Score: 0.004
  37. Direct Absorb bioresorbable scaffold implantation in acute coronary syndrome. Kardiol Pol. 2018; 76(10):1434-1440.
    View in: PubMed
    Score: 0.003
  38. Cardiac computed tomography compared with two-dimensional transesophageal echocardiography for the detection and assessment of atrial septal pouches. Int J Cardiovasc Imaging. 2018 Aug; 34(8):1305-1313.
    View in: PubMed
    Score: 0.003
  39. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry. JACC Cardiovasc Interv. 2017 12 26; 10(24):2548-2556.
    View in: PubMed
    Score: 0.003
  40. Anatomy of the mitral subvalvular apparatus. J Thorac Cardiovasc Surg. 2018 05; 155(5):2002-2010.
    View in: PubMed
    Score: 0.003
  41. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. Eur Heart J. 2017 11 07; 38(42):3124-3134.
    View in: PubMed
    Score: 0.003
  42. Chronic obstructive pulmonary disease affects the angiographic presentation and outcomes of patients with coronary artery disease treated with percutaneous coronary interventions. Pol Arch Intern Med. 2018 01 31; 128(1):24-34.
    View in: PubMed
    Score: 0.003
  43. Predictors of in-hospital effectiveness and complications of rotational atherectomy (from the ORPKI Polish National Registry 2014-2016). Catheter Cardiovasc Interv. 2018 10 01; 92(4):E278-E287.
    View in: PubMed
    Score: 0.003
  44. Comparative assessment of three drug eluting stents with different platforms but with the same biodegradable polymer and the drug based on quantitative coronary angiography and optical coherence tomography at 12-month follow-up. Int J Cardiovasc Imaging. 2018 Mar; 34(3):353-365.
    View in: PubMed
    Score: 0.003
  45. Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial. Eur Heart J Acute Cardiovasc Care. 2018 Jun; 7(4):339-347.
    View in: PubMed
    Score: 0.003
  46. Morphologic variability of the mitral valve leaflets. J Thorac Cardiovasc Surg. 2017 12; 154(6):1927-1935.
    View in: PubMed
    Score: 0.003
  47. Diagnostic Accuracy of Coronary CT Angiography for the Evaluation of Bioresorbable Vascular Scaffolds. JACC Cardiovasc Imaging. 2018 05; 11(5):722-732.
    View in: PubMed
    Score: 0.003
  48. Left atrial accessory appendages, diverticula, and left-sided septal pouch in multi-slice computed tomography. Association with atrial fibrillation and cerebrovascular accidents. Int J Cardiol. 2017 Oct 01; 244:163-168.
    View in: PubMed
    Score: 0.003
  49. Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudy. Eur Heart J Cardiovasc Imaging. 2017 May 01; 18(8):870-879.
    View in: PubMed
    Score: 0.003
  50. High sensitive TROponin levels In Patients with Chest pain and kidney disease: A multicenter registry - The TROPIC study. Cardiol J. 2017; 24(2):139-150.
    View in: PubMed
    Score: 0.003
  51. Scaffold and edge vascular response following implantation of everolimus-eluting bioresorbable vascular scaffold: a 3-year serial optical coherence tomography study. JACC Cardiovasc Interv. 2014 Dec; 7(12):1361-9.
    View in: PubMed
    Score: 0.003
  52. Predictors of coronary and carotid atherosclerosis in patients with severe degenerative aortic stenosis. Int J Med Sci. 2013; 10(10):1361-6.
    View in: PubMed
    Score: 0.002
  53. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes. JACC Cardiovasc Imaging. 2012 Mar; 5(3 Suppl):S42-52.
    View in: PubMed
    Score: 0.002
  54. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation. 2011 Apr 26; 123(16):1745-56.
    View in: PubMed
    Score: 0.002
  55. Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study. EuroIntervention. 2011 Apr; 6(9):1110-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.